department

Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access

therapeutic area

Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease

location & type

Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →

when

Latest
Archive

by source

All Sources
Sources Page

by activity

Most Active
Biggest Pipelines
Recently Active

hiring

Companies Hiring Now
Big Pharma Roles
All Companies →

Drugs & Pipeline

intelligence

Drugs
Patent Cliff

research

Publications
Topics

window

Next 90 Days
All (incl. Past)

by type

PDUFAs
Approvals
Earnings
Readouts

Sign In Subscribe

pharmadog

fetch the data · sniff the signal

Discover

Calendar
Drugs
Companies
News

Hubs

Topics
Jobs
Patent cliff
Publications

Tools

Compare
Search
Bookmarks

Trust

About
Sources
Contact

Legal

Privacy
Terms
Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

home
jobs
news
cal
search

Genetix Biotherapeutics Inc · pharmadog

PUBLIC COMPANY

Genetix Biotherapeutics Inc

updated 1mo ago

community read0 votes

pipeline

3

marketed

2

phase 3

1

catalysts ytd

0

approvals ytd

0

recalls ytd

0

Pipeline(3)

pipeline depth3 products

1Phase 32Marketed

betibeglogene autotemcel

Beta Thalassaemia

elivaldogene autotemcel

Adrenoleukodystrophy (X-Linked Adrenoleukodystrophy (X-ALD))

lovotibeglogene autotemcel

Sickle Cell Disease

Hemoglobin subunit beta

Upcoming

no upcoming catalysts on record

Recent(90d)

nothing in the last 90 days

view all catalysts →

🐶 Hiring Signal

No open roles indexed yet — view Genetix Biotherapeutics Inc jobs →

News

no news has mentioned this company yet

identifiers

source

globaldata

top tags

Sickle Cell Disease1

mentioned in

0news items

entity-linker matched

Active trials

—A Study of Participants With Cerebral Adrenoleukodystrophy (CALD) Treated With Elivaldogene Autotemcelrecruitingn=120
—Long-term Follow-up of Subjects With Transfusion-Dependent β-Thalassemia (TDT) Treated With Ex Vivo Gene Therapyactive not recruitingn=66
—Long-term Follow-up of Subjects with Sickle Cell Disease Treated with Ex Vivo Gene Therapyenrolling by invitationn=85
phase2A Study Evaluating the Safety and Efficacy of Lovo-cel in Severe Sickle Cell Diseasecompletedn=54
—Long-term Follow-up of Participants With Cerebral Adrenoleukodystrophy Who Were Treated With Lenti-D Drug Productactive not recruitingn=64
—A Study of Participants with Β-Thalassemia Treated with Betibeglogene Autotemcelrecruitingn=150
phase3A Study Evaluating Gene Therapy With BB305 Lentiviral Vector in Sickle Cell Diseaseactive not recruitingn=35
phase3A Clinical Study to Assess the Efficacy and Safety of Gene Therapy for the Treatment of Cerebral Adrenoleukodystrophy (CALD)completedn=35

more trials →

comments(0)

5-min edit window · permanent after that

sign in to leave a comment · permanent archive after 5 minutes

no comments yet — first sniff?